Disorders of oxidised haemoglobin.
暂无分享,去创建一个
[1] R. Estabrook,et al. Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions. , 1971, Archives of biochemistry and biophysics.
[2] N. Borgese,et al. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia. , 1995, American journal of human genetics.
[3] T. Miale,et al. Leukocyte diaphorase deficiency in congenital methemoglobinemia: a valuable prognostic indicator. , 1977, Biology of the neonate.
[4] D. L. Cinti,et al. Biochemical properties of cytochrome b5-dependent microsomal fatty acid elongation and identification of products. , 1980, The Journal of biological chemistry.
[5] J. Hoyer,et al. Hb Chile [beta28(B10)Leu-->Met]: an unstable hemoglobin associated with chronic methemoglobinemia and sulfonamide or methylene blue-induced hemolytic anemia. , 1999, Hemoglobin.
[6] C. Junien,et al. Generalised deficiency of cytochrome b5 reductase in congenital methaemoglobinaemia with mental retardation , 1975, Nature.
[7] K. Titani,et al. A New Abnormal Fetal Hemoglobin, Hb FM-Osaka (α2γ263His→Tyr) , 1980 .
[8] P. Laspe,et al. Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH‐cytochrome b5 reductase (diaphorase 1) gene , 2001, Human mutation.
[9] J. Prchal,et al. A novel mutation found in the 3' domain of NADH-cytochrome B5 reductase in an African-American family with type I congenital methemoglobinemia. , 1996, Blood.
[10] S. Iwanaga,et al. Complete amino acid sequence of NADH-cytochrome b5 reductase purified from human erythrocytes. , 1986, Journal of biochemistry.
[11] M. Bewley,et al. The structure of the S127P mutant of cytochrome b5 reductase that causes methemoglobinemia shows the AMP moiety of the flavin occupying the substrate binding site. , 2003, Biochemistry.
[12] E. Krenzelok,et al. Environmentally-induced methemoglobinemia in an infant. , 1992, Journal of toxicology. Clinical toxicology.
[13] K. Inaka,et al. Crystal structure of NADH-cytochrome b5 reductase from pig liver at 2.4 A resolution. , 1995, Biochemistry.
[14] Y. Fukumaki,et al. Two novel mutations in the reduced nicotinamide adenine dinucleotide (NADH)-cytochrome b5 reductase gene of a patient with generalized type, hereditary methemoglobinemia. , 1996, Blood.
[15] R. Wanders,et al. A case of methemoglobinemia type II due to NADH‐cytochrome b5 reductase deficiency: Determination of the molecular basis , 2000, Human mutation.
[16] S. Shibata,et al. Hemoglobin M1: Demonstration of a New Abnormal Hemoglobin in Hereditary Nigremia. , 1960 .
[17] N. Oshino,et al. A function of cytochrome b5 in fatty acid desaturation by rat liver microsomes. , 1971, Journal of Biochemistry (Tokyo).
[18] S. Brennan,et al. HB Auckland [α87(F8)his→ASN]: A new Mutation of the Proximal Histidine Identified by Electrospray Mass Spectrometry , 1997 .
[19] S. Bradberry. Occupational Methaemoglobinaemia , 2003, Toxicological reviews.
[20] K. Shirabe,et al. An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme. , 1994, The Journal of biological chemistry.
[21] M. Bewley,et al. The structure and biochemistry of NADH-dependent cytochrome b5 reductase are now consistent. , 2001, Biochemistry.
[22] E. Demaeyer,et al. The prevalence of anaemia in the world. , 1985, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.
[23] Yao Wan,et al. Identification of a novel point mutation (Leu72Pro) in the NADH‐cytochrome b5 reductase gene of a patient with hereditary methaemoglobinaemia type I , 1998, British journal of haematology.
[24] J. Priest,et al. Mutant fetal hemoglobin causing cyanosis in a newborn. , 1989, Pediatrics.
[25] L. Shenkman,et al. Fatal methemoglobinemia caused by inadvertent contamination of a laxative solution with sodium nitrite. , 1992, Israel journal of medical sciences.
[26] M. L. Efron,et al. Chemical studies of several varieties of Hb M. , 1961, Proceedings of the National Academy of Sciences of the United States of America.
[27] N. Borgese,et al. Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type). , 1992, The Journal of biological chemistry.
[28] Y. Sakaki,et al. Serine-proline replacement at residue 127 of NADH-cytochrome b5 reductase causes hereditary methemoglobinemia, generalized type. , 1990, Blood.
[29] J. Kaplan,et al. Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. , 1995, Blood.
[30] F. Xie,et al. A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia. , 2000, Blood.
[31] K. Higasa,et al. Molecular basis of hereditary methaemoglobinaemia, types I and II: two novel mutations in the NADH‐cytochrome b5 reductase gene , 1998, British journal of haematology.
[32] M. Eppink,et al. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b(5) reductase gene leading to methemoglobinemia type I. , 2001, Blood.
[33] E. Harley,et al. Recessive congenital methaemoglobinaemia type II, a new mutation which causes incorrect splicing in the NADH-cytochrome b5 reductase gene , 1997, Journal of Inherited Metabolic Disease.
[34] M. Kiese. THE BIOCHEMICAL PRODUCTION OF FERRIHEMOGLOBINFORMING DERIVATIVES FROM AROMATIC AMINES, AND MECHANISMS OF FERRHEMOGLOBIN FORMATION , 1966 .
[35] Q. Gibson. The reduction of methaemoglobin in red blood cells and studies on the cause of idiopathic methaemoglobinaemia. , 1948, The Biochemical journal.
[36] E. Caspi,et al. Mechanism of C-5 double bond introduction in the biosynthesis of cholesterol by rat liver microsomes. , 1976, The Journal of biological chemistry.
[37] K. Senger,et al. Fatal outcome of methemoglobinemia in an infant. , 1987, JAMA.
[38] G. Irken,et al. Congenital methaemoglobinaemia Type I in a Turkish infant due to a novel mutation, Pro144Ser, in NADH-cytochrome b5 reductase. , 2004, The hematology journal : the official journal of the European Haematology Association.
[39] S. Ebbe,et al. Clinical and laboratory features of two variants of methemoglobin M disease. , 1959, The Journal of laboratory and clinical medicine.
[40] Y. Sakaki,et al. Structural role of serine 127 in the NADH-binding site of human NADH-cytochrome b5 reductase. , 1991, The Journal of biological chemistry.
[41] D E Hultquist,et al. Catalysis of methaemoglobin reduction by erythrocyte cytochrome B5 and cytochrome B5 reductase. , 1971, Nature: New biology.
[42] M. McMullin,et al. Familial idiopathic methemoglobinemia revisited: original cases reveal 2 novel mutations in NADH-cytochrome b5 reductase. , 2002, Blood.
[43] Y. Sakaki,et al. The organization and the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene. , 1989, Gene.
[44] O BODANSKY,et al. Methemoglobinemia and methemoglobin-producing compounds. , 1951, Pharmacological reviews.
[45] A. Tomoda,et al. Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency. , 1991, American journal of human genetics.
[46] D. Płochocka,et al. Compound heterozygosity of two missense mutations in the NADH‐cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemia , 2003, European journal of haematology.
[47] P. Board. NADH-ferricyanide reductase, a convenient approach to the evaluation of NADH-methaemoglobin reductase in human erythrocytes. , 1981, Clinica chimica acta; international journal of clinical chemistry.